NIH Plans $15M for Phase II COBRE Grants | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Center for Research Resources plans to award $15 million in 2011 for Phase III funding for its Centers of Biomedical Research Excellence (COBRE) program.

Funded through the Institutional Development Award Program, the COBRE grants support development of the biomedical research infrastructure and faculty that are necessary to establish and maintain core facilities and multidisciplinary, collaborative programs based on shared scientific interests.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.